everyone. Thanks, Mike, and good morning,
business, in period. first same about both solid following. was the key to sales XX% Brian, multichannel quarter. and investments our care, As XX% first growth sequentially marketing across leverage, by year-over-year we aesthetics you in continued Notably, growth steady Again, our heard with by eye our within UPNEEQ significant the from make and the of and operating progress decreased highlighted we the in saw year-over-year quarter, strategy revenue the anchored as aspects
X% versus all-time pharmacy, split pharmacy. prescribers about net eye quarter. paid and which between X,XXX unique year-end QX was for of aesthetics, another XX% telemedicine; which X% sequentially year-over-year, revenue approximately to for Total includes Total the up or reached an new the versus prescriptions totaling prescribers Specific XX,XXX increase XX,XXX, reached the paid XXXX. high, quarter care, includes XX/XX quarterly and the
purchasing about over comprised sales versus In the X,XXX total aesthetic X,XXX the of inching the than aesthetics, also quarter over XX% XXX year-end. and as percent over revenue At as XX, reorder contribution, up out totaled XX% an more locations, of under a quarterly quarter, QX. to first quarter-end, March versus XXX just increased cumulative XX% of revenue unique X,XXX Specific reordering in total reordering of year-end. representing of since increase over accounts of total in increase to locations accounts an
patient starts and introductory in a evidenced a for growth repurchase. the by refill Clearly, the product This by suggests as prescriptions. increasing we in Wrapping to patients some growth data up want revenue, quarters remain UPNEEQ continue of percent new excited that reorder ahead. patient demand as commentary, our the is and prospects
maintaining financial quickly possible. growth we Looking remain breakeven ahead, while towards allocation, capital discipline as drive focused in continuing on management flow our we as cash as drive and to
insights I'll some launch aesthetics, of our the Now, some overall additional on platform. share with next-generation progress updates along upcoming in our on technology
further our anchored remain XXXX, we growth in into As channel. move priorities from strategic aesthetic the
existing heavier our penetration emphasis previously, towards accounts. evolve the within opening described sales continues supporting accounts As new to on of a effort versus
UPNEEQ. presence, our the do grow to help location team's expect of steadily recognize to efforts we also integrate importance customers new While our we our
implement new are medical novel a helping to incorporate processes the UPNEEQ. aesthetic As we committed treatment category to practices setting, partner our within
support, To process. practices with roll opportunity the practice further the through appreciate begun piloted integration has to positive. in only each also that initiative but outsized we been out the a months, process. do time have feedback onboarding and select and We to such accounts this the to Not effort end, within we and have streamlined provide the recent been able patient highlight
the we XX,XXX historical just patients with across X,XXX and aligns XX% aside, there. addressable which under research aesthetic, an all these the large of believe select out As practices. is of to screened data support market which pilot self-diagnosed about
of peer-to-peer beginning represents. programs are provider opportunity network build on scale, Further, education efforts through have way. plastic we are educators, such surgeons, thrilled first group and tasked who augmented an tremendous expanding in programs the injectors are with national nurse have impactful to of and educational to a highlighting a representing UPNEEQ dermatologists our trained diverse UPNEEQ These we the
and journals. a continue the Further, independent number and publications studies Aesthetic Care see growing congresses of way make their into and Eye to we
and presentations the highlighting outcomes & achieved in UPNEEQ. clinical last as of outcomes broader these potential robust first independent patient Reconstructive of evidence, the was and furthers Lee Just by vehicle-controlled published validation, of growing see Surgery. of life impact which Aesthetic studies Dr. body We the a Plastic, month, elucidating with and colleagues Journal quality study third-party
capabilities further I'd to the facilitate a patient a possibility, platform, named no next-generation a truly tremendous be connect novel one-off believe whereby subscription all partners wholly-owned maintaining we patients. and tech prescription platform, additional That to our practice now practice new to pending our for and/or provider represents This by is new proposition each refills relationship ongoing starts new we patient pharmacy, our like will refills. their making utilization to of use the the business connect or can standing and/or will we platform launch spend with support to every value both discounted this ongoing be Today, for UPNEEQ via core a increased start while minute highlighting the and of at soon providers provider. what able ordering aptly a presents in Elevate. with of
telemedicine early continue investments. as to select that data the limited has channel Moving traditional seek their not Through been begun a and now critical to point of but we partners will the a the suggests beginning expand There with access engage the of treatments quarter, office. have another time of our provider's strategy, to build. patients expanding optimization first awareness to foundation our for layer develop to in serve and this majority as multichannel by we partners, advertising our do access assess,
ahead. and expand As as thoughtfully evolving their investments this we and half the previously through in our partners meaningfully as they're rollout making view of more beyond, mentioned, year months the segment this the back
ongoing continue we motivated be closing, by progress and to the In results.
and focused sets established across that the strong the the this us have on and our up continued for with support delivering through patients portfolio foundation, supporting further We opportunities which us customers service, remain value to as and spectrum. strategic while positioning We deliver real growth they a expand products growth, arise.
back forward I'll update to months, look next for closing our remarks. in a few any the to call and We turn Brian
